On the basis of this analysis, we found that luminal CD133+, basal cell, and stem cell enriched MECs were able to give rise to tumors of both basal and luminal subgroups (Fig. 3), with no correlation to tumor histology or ESR1 status (data not shown). The gene discussed is ESR1; the disease is neoplasm.